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Abstract (200 words) 
Systemic autoimmune responses are a hallmark feature of generalized autoimmune diseases, 
including systemic lupus erythematosus (SLE) and systemic sclerosis (SSc)1. These clinically 
heterogeneous conditions are characterised by immune‐mediated tissue damage in multiple 
organs, caused by aberrant responses of the adaptive immune system. However, the processes 
underlying the loss of tolerance against self constituents is unresolved. The lymphotoxin‐β 
receptor (LTβR) functions as receptor for both membrane‐bound lymphotoxin (LTα1β2) and 
LIGHT (TNF superfamily member 14)2. LTβR controls the development of secondary lymphoid 
organs, and is continuously required in adults for homeostasis and structural architecture of the 
thymus and secondary lymphoid organs. Using mice deficient in LT and Hox11, we report that 
approximately 25% of mice lacking secondary lymphoid organs spontaneously develop 
antinuclear antibodies. Interestingly, this phenotype is not caused by a defect in central tolerance. 
Rather, cell-specific deletion and in vivo LT blockade link these systemic autoimmune responses 
to gut associated lymphoid tissue in the neonatal period of life. We further demonstrate that 
autoantibody production is influenced by the presence of commensal gut flora, especially 
segmented filamentous bacteria, IL-17 receptor signalling and the production of IgA. Together, 
these data indicate that neonatal colonization of gut microbiota influences generalized 
autoimmunity in adult life. 
  
Manuscript 
Autoantibodies against nuclear antigens are a hallmark feature of generalized autoimmune 
diseases1. Immunodominant autoantigens recognized by systemic autoantibodies are often DNA- 
or RNA-associated protein complexes. Underlying mechanisms that mediate the breach of 
tolerance against these autoantigens are only partially understood. In autoimmune-prone strains 
of mice, antigen-producing cells have been located in secondary lymphoid tissue, and both 
extrafollicular and germinal centre responses have been implicated in the production of such 
autoantibodies3,4. 
LT-deficient mice serve as a prototypic model for studying the influence of secondary lymphoid 
organs in immune processes. Although antibody responses are impaired in LT-deficient animals 
due to absence of follicular dendritic cell networks, germinal centre formation and somatic 
hypermutation can still occur5. Based on the presence of perivascular lymphocytic infiltrates in 
multiple organs as well as organ specific autoantibodies an autoimmune phenotype has been 
defined for the LT-deficient animals6. However, the role of the disturbed thymic medulla in this 
autoimmune phenotype is a matter of controversy7-9. Whether systemic autoimmune responses do 
occur in absence of secondary lymphoid tissues is another area of uncertainty6,7. Given 
conflicting reports on systemic autoimmune responses in Ltbr−/− mice, we sought to investigate 
whether autoantibodies directed against nuclear antigens can appear in absence of secondary 
lymphoid tissues utilizing Ltbr−/− mice. 
We found that ~25% of LTβR-deficient mice developed systemic autoimmune responses by three 
months of age (Fig. 1a) using a validated immunodetection system for a broad range of nuclear 
antigens (Supplementary Fig. 1). The immunoassay system identified anti-extractable nuclear 
antigen (ENA) antibodies, including anti-U1RNP, anti-Sm, anti-Scl70/Topoisomerase-I, anti-
Centromere protein B, anti-SSA/Ro52 and anti-Jo1 (Fig. 1b and b). Antibodies to these 
autoantigens are strongly associated with SLE, SSc and polymyositis1. In contrast, no anti-
dsDNA was found (Supplementary Fig. 2). By six months of age, the prevalence of 
autoantibodies remained the same, but more mice developed multiple reactivities (Fig. 1b and 
1c). We could not detect any autoimmune reactivity at six weeks of age despite immune 
maturation, suggesting a delayed stochastic penetrance of the autoimmune phenotype 
characteristic in most autoimmune diseases. As LT-deficient animals have a spleen, we sought to 
determine whether autoantibodies can be generated in asplenic mice by intercrossing Hox-11−/− 
and Ltbr
 −/− mice. These double knock-out mice still developed the pathological autoantibody 
responses at the same prevalence, demonstrating that aberrant systemic autoimmune responses 
can develop in the complete absence of secondary lymphoid organs (Fig. 1a). 
Histological examination of Ltbr
 −/− mice confirmed the presence of lymphocytic infiltrates in 
multiple organs. Given the association of systemic autoimmune responses with generalised 
autoimmune disease, we specifically looked for characteristic pathological features. However, 
compared to wild‐type mice, no difference was observed in kidney damage, and skin and 
oesophageal sclerosis (Supplementary Fig. 3). Furthermore, renal histology and proteinuria were 
not different between antibody positive and negative Ltbr
 −/− mice (data not shown). 
We then evaluated whether structural defects in LT-deficient mice lead to systemic autoimmune 
responses. To this end, we used an LTβR-Fc fusion protein, which acts as a soluble decoy 
receptor blocking LTαβ and LIGHT10. Blocking LTβR signalling at various phases of ontogeny 
and early postnatally results in the temporally patterned absence of secondary lymphoid organs 
(lymph nodes, Peyers’ patches (PP) and cryptopathes (CP))10-12. We observed that blocking 
LTβR signalling during late ontogeny through six weeks of age resulted in the appearance of 
autoantibodies at the age of three months (Fig. 1d), and as demonstrated previously, these mice 
lacked CP, PP and ILF (data not shown). In contrast, mice lacking peripheral lymph nodes and 
PP by blocking LTβR signalling during early ontogeny did not develop autoantibodies. In 
addition, blocking LTβR signalling during adulthood, which disrupts splenic architecture also did 
not result in autoantibody formation (Fig. 1d). To rule out a role of LTβR signalling in the 
thymus during the perinatal window, we performed thymus transplant experiments. Fetal thymi 
from Ltbr−/− or wild‐type mice were depleted of hematopoietic cells and then grafted under the 
kidney capsules of nude mice, creating Ltbr−/−→nude mice and wild‐type→nude mice. Twelve 
weeks after engraftment, mice were sacrificed and T cell repopulation was verified in the liver 
and spleen by flow cytometry (Supplementary Fig. 4a and 4b). Ltbr−/− and wild‐type thymi 
contained approximately equal number of thymocytes, with similar distribution among the 
different T cell subsets (Supplementary Fig. 4a). Levels of total IgG were also not different 
between the two groups (Supplementary Fig. 4c). Importantly, no autoantibodies could be 
detected in the serum samples of nude mice engrafted with LTβR-deficient thymic lobes 
(Supplementary Fig. 4d). We thus concluded that systemic autoimmune responses can develop in 
absence of CP and ILF. 
We next wanted to resolve which membrane LT-expressing cell type in the lamina propria of the 
gut was involved in maintenance of tolerance against nuclear antigens. To this end, we generated 
mice deficient in LTβ in T cells (T-Ltb−/−), B cells (B-Ltb−/−) or RORγt+ cells (Rorγt-Ltb−/−). We 
could only detect autoantibodies with a similar spectrum as Ltbr−/− in mice lacking membrane LT 
in RORγt positive cells (Fig. 1e). To resolve which LTβR-expressing cells in the lamina propria 
are involved in the maintenance of the tolerance, we performed reciprocal bone marrow transfer 
experiments between wild-type and Ltbr−/− mice. As shown in Figure 1f, both wild-type→Ltbr−/− 
and Ltbr−/−→wild-type chimeras developed autoantibodies. We thus conclude that 
communication via the LT-LTβR axis between RORγt+ innate lymphoid cells (ILC) and both 
radio-resistant and bone marrow-derived cells is essential to maintain tolerance.  
RORγt+ ILC have been shown to be essential in the defence of epithelial surfaces, and play an 
important role in the intestinal homeostasis with symbiotic microbiota by the production of IgA, 
IL-17 and IL-22 production13. This regulatory control in the gut prompted us to examine the 
relationship between the gut microbiota and autoantibody production. Moreover, early postnatal 
blocking of LTβR signalling leads to a 10‐fold expansion of the normal ileal microbiota, 
including bacteria belonging to the Clostridiales, Bacteroides and Enterobacteriaceae groups12. 
We assessed whether elimination of the gut microbiota influenced autoantibody production. 
Pregnant mice and their offspring were treated with broad‐spectrum antibiotics until the age of 12 
weeks. As previously observed in germfree mice, this caused a significant enlargement of the 
caecum (data not shown). Ltbr−/− mice receiving antibiotics had reduced prevalence of 
autoantibodies compared to untreated animals (Fig. 2a, upper panel). To further substantiate a 
role for the gut microbiota, we treated germ free C57BL/6 mice with the LTβR-Fc fusion protein 
from gestational day 18 until six weeks after birth as described above. Similarly, germ free 
animals had a reduced prevalence of autoantibodies (Fig. 2a, lower panel). We next assessed 
whether gut microbiota composition differed between wild-type, antibody-positive and -negative 
LTβR deficient animals existed. In a first screening, we performed a community profiling with 
denaturing gradient gel electrophoresis (DGGE) on the luminal, mucosal and fecal microbiome. 
As shown on Figure 2b, we observed genotype and antibody-specific clustering of the three 
animal groups. Cloning and sequencing of the gel band that differed most between the groups 
revealed a species belonging to the segmented filamentous bacteria (SFB), characterizing animals 
with multiple reactivities as a separate group. These data were confirmed by quantitative PCR 
with primers specific for SFB genes (Fig. 2c). Histological analyses of different gut parts 
comparing antibody positive and negative LTβR deficient animals revealed no inflammatory 
differences (Supplementary Fig. 5 and Supplementary Fig. 6). SFB are important for inducing a 
robust T-helper cell type 17 population in the small-intestinal lamina propria of the mouse gut14. 
To assess the potential role of IL-17 or IL-25 in the model as an effector cytokine, we treated IL-
17R-deficient mice with the LTβR-Fc fusion protein from gestational day 18 until six weeks after 
birth as described above. In contrast to wild-type mice, this treatment did not induce significant 
systemic autoimmune responses (Fig. 2d). In BXD2, a mouse model for lupus, IL-17 was also 
identified as an important effector cytokine for systemic autoimmune responses15. 
ILF and PP contain the stromal micro‐environment for IgA production, a critical antibody that 
helps maintain gut homeostasis16. We determined IgA levels in animals with and without 
multiple autoantibodies. As shown in Figure 3a multiple anti-ENA positive animals had markedly 
lower serum IgA levels compared to negative animals. A similar reduction of IgA levels, and IgA 
positive cells in the terminal ileum, was observed in multiple anti-ENA positive mice treated with 
LTβR-Fc fusion protein (data not shown). In addition, a decrease in IgA but not in IgG levels, 
was also apparent in human SLE patients, compared to other forms of arthritis lacking antinuclear 
antibodies such as rheumatoid arthritis or spondyloarthritis (Fig. 3b and 3c). SFB colonization of 
the small intestine has previously been shown to increase IgA producing B cells17. Furthermore, 
IgA has been implicated in controlling SFB colonization18. We report that in the absence of LT 
IL-17R-dependent systemic autoimmune responses are associated with SFB colonization and 
decreased IgA levels. Overall, our findings enforce a new paradigm that neonatal colonization of 
the gut impacts systemic autoimmune responses against nuclear antigens in adulthood by 
increased colonization of the intestine by SFB. 
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Methods 
Mice 
C57BL/6 and nude mice (C57BL/6 background) were originally purchased from The Jackson 
Laboratory. Mice deficient in LTα19 (backcrossed 8 times on C57BL/6), LTβR20 (backcrossed 6 
times), LIGHT21 (backcrossed 6 times), HOX1122 (backcrossed 10 times) and IL17R23 
(backcrossed more than 10 times) have been described previously. Ltb−/−, T-Ltb−/−, B-Ltb−/− and 
Rorγt-Ltb-/- were generated by crossing LTβ-floxed mice24 with K5-cre25, CD4‐cre26, mb1‐cre27 
and RORγt‐cre28, respectively. MRL/lpr−/− and (NZB/NZW)F1 mice were purchased from 
Harlan Europe. Sera from NOD mice were kindly provided by Prof C. Mathieu (University 
Hospital Leuven, Belgium). Pristane-induced lupus in C57BL/6 was performed as described 
previously29. Germ free C57BL/6 were obtained from the INRA Anaxem germfree animal 
facilities (Jouy-en-Josas, France) and housed in isolators. Other mice were housed and bred in a 
specific pathogen‐free facility. All animal procedures were approved by the Institutional Animal 
Care and Ethics Committee of Ghent University. 
 
Patients 
Serum samples for testing IgA and IgG levels were selected from previously described cohorts of 
patients with systemic lupus erythematosus30, rheumatoid arthritis31 and spondyloarthritis32. This 
study was conducted after approval by the ethical committee of the Ghent University Hospital 
and informed consent was obtained from these patients. 
 
Antibodies, fusion protein, antibiotics and ELISA 
Pregnant mice were injected simultaneously i.v. and i.p. with 50 μg of LTβR-Fc on day 11 and 
day 15 of gestation, or only on day 18 of gestation. When the mother was injected only at day 18, 
progeny received weekly i.p. injections with 25 μg of LTβR‐Fc (continuous) starting at day 7 
after birth until the age of 6 weeks. Controls consisted of C57BL/6 mice treated with control IgG. 
In addition, adult C57BL/6 mice (8 weeks) were injected i.p. weekly with 100 μg of LTβR‐Fc or 
control immunoglobulin for 7 weeks. Ampicillin, streptomycin and colistin (Sigma‐Aldrich) were 
supplied to mice in the drinking water at a concentration of 1 g/l, 5 g/l and 1 g/l, respectively. 
Murine IgA and human IgA and IgG antibodies were detected with ELISA according to the 
manufacturer’s instructions (eBioscience). 
 Thymus transplants 
Thymi were isolated from newborn Ltbr−/− or wild‐type mice and cultured in 1.35 mM 
2‐deoxyguanosine (Sigma‐Aldrich) for 5 days to deplete bone marrow‐derived cells. Two thymic 
lobes were then transplanted under the kidney capsule of adult nude mice9. Mice were bled 6 
weeks after the procedure to verify the presence of circulating T cells by flowcytometry. After 12 
weeks mice were bled and sacrificed. Thymic lobes, liver and spleen cells were analyzed by flow 
cytometry. 
 
Bone marrow transfers 
Bone marrow was isolated from the femur and tibia of Ltbr−/− or wild‐type mice. Three million 
bone marrow cells were injected in the liver of sublethally-irradiated (400 rad) 7 day-old 
C57BL/6 and LTβR deficient recipient mice. 
 
Anti‐extractable nuclear antigen and anti‐dsDNA antibodies 
Anti‐ENA were detected by line immunoassay (INNO‐LIA ANA Update, Innogenetics NV). The 
nylon strips were incubated with serum at a 1/200 dilution. Following washing, a 1:2500 dilution 
of an alkaline phosphatase‐conjugated anti‐mouse IgG was added (Chemicon). After washing, the 
reaction was revealed with the chromogen 5‐bromo‐4‐chloro‐3‐indolyl phosphatase, producing a 
dark brown color in proportion to the amount of specific autoantibody in the test sample. 
Sulphuric acid was added to stop the color development. The cutoff of the reactivities was 
determined by testing 20 serum samples from 6-month-old C57BL/6 mice. None produced any 
background staining higher than a 1:12800 dilution of a strong anti‐RNP‐A reactivity of a 
MRL/lpr−/− mouse. Thus, we considered a higher intensity as a positive test result. The assay 
contains the following recombinant and natural antigens: SmB, SmD, RNP‐A, RNP‐C, RNP‐70k, 
Ro52/SSA, Ro60/SSA, La/SSB, CenpB, Topo‐I/Scl70, Jo‐1, ribosomal P, and histones. 
Anti‐dsDNA IgG antibodies were detected with ELISA according to the manufacturer’s 
instructions (Alpha Diagnostic International). 
 
Histopathology 
Tissues for histological examination were fixed in 4% buffered formaldehyde and embedded in 
paraffin. Sections were stained with haematoxylin and eosin, periodic‐acid Schiff, silver staining 
and Masson’s trichrome using the standard technique. For electron microscopy, intestinal 
samples were fixed in 0.1 M cacodylate buffer containing 4% paraformaldehyde and 5% 
glutaraldehyde during 48 h. Then, samples were washed overnight with 0.1 M Sodium cacodylate 
buffer. Following postfixation in 1% osmium tetroxide for 3 h, samples were dehydrated in a 
series of alcohol (15’ 50%, 15’ 70%, 15’ 90% and 3 times 30’ 100%) and embedded in Epon 
medium (Aurion). Semithin sections of 1 µm were cut and stained with toluidine blue to select 
the most appropriate area of the intestinal sample to be visualized. Ultrathin sections of 60 nm 
were cut and contrasted with uranyl acetate and lead nitrate, followed by imaging with a Zeiss 
TEM900 transmission electron microscope (Carl Zeiss) at 50 kV. De-identification and coding of 
slides was done so that a blinded evaluation could be performed. Slides were scored by trained 
pathologists (LA and CAC, for the gut sections, AD for the renal sections). Renal slides were 
scored as described previously.33 Briefly, for glomerular damage, 10 random glomeruli of each 
animal were scored using a semi-quantitative grading system. In this grading system, a grade 0 
corresponds with specimens with no glomerular lesions, grade I lesions show minimal mesangial 
thickening, grade II lesions contain increases in both mesangium and glomerular cellularity, and 
grade III lesions contain the preceding features plus superimposed inflammation and/or capsular 
adhesions. Grade IV lesions show obliteration of glomerular architecture involving more than 
70% of the glomeruli. Furthermore, glomerular crescents, interstitial inflammation and vascular 
inflammation were described. Dermal sclerosis and esophageal sclerosis was determined using 
ImageJ to measure the thickness of dermis and submucosa. Inflammatory scores of different part 
of the gut were performed according to an adapted scoring scheme34 (Supplementary Fig. 5b). 
 
Flow cytometry 
Liver mononuclear cells were isolated using an adjusted 33% Percoll gradient (GE Healthcare)35. 
Cell suspensions from thymus and spleen were prepared by conventional methods. Mononuclear 
cells were isolated from peripheral blood using a Ficoll Paque Plus gradient (GE Healthcare). 
Cell stainings were performed as described previously35. Cells were acquired on a FACSCanto II 
(Becton Dickinson) flow cytometer and analyzed using FlowJo software (Tree Star). Primary 
antibodies used were from eBioscience: anti‐TCRβ (H57‐597), anti‐CD4 (L3T4), anti‐CD8 
(Ly‐2), anti‐FOXP3 (FJK‐16s) and B220–APC‐Cy7. 
 
Analysis of the gut flora 
The most prominent shifts within the microbiota were monitored via denaturing gradient gel 
electrophoresis (DGGE). After DNA extraction36 and PCR37, gels were run using an Ingeny 
PhorU apparatus (Ingeny International). DNA-fragment bands on the DGGE gel that 
distinguished autoantibody positive from negative samples on the DGGE gel, were identified 
through sequence analysis. Specific bands were cut from the gel, after which the 180 bp sized 
fragment were sequenced (AGOWA). Normalization and further analysis of the gels was carried 
out using BioNumerics software v5.10. To identify the band of interest in more phylogenetic 
detail, a clone library was made from the samples of interest. PCR was performed on the sample 
with primers F27/R1492. PCR products were cut from the gel, purified (QIAquick Gel Extraction 
Kit, QIAGEN) and cloned with a TOPO TA Cloning Kit with PCR2.1- TOPO Vector 
(Invitrogen). Clone DNA was amplified with primers M13F/M13R, after which nested PCR was 
followed with DGGE primers GC-338F/518R. Clones from which the DNA band on DGGE 
matched with the DNA band of interest (distinctive between autoantibody positive and negative) 
were sent for sequencing (AGOWA). Sequences (480 bp) were manually inspected and compared 
with databases at the NCBI website (http://blast.ncbi.nlm.nih.gov/blast.cgi). Following the 
identification of segmented filamentous bacteria (SFB) as distinctive DNA band between 
autoantibody positive and negative mice, we next performed a quantitative analysis of SFB with 
qPCR using primers SFB736F and SFB844R as reported previously.38 
 
Statistical analysis 
For categorical data analyses, Fisher’s exact tests were used, whereas continuous data were 
analyzed by student’s t-tests, Mann Withney U tests or ANOVA with Bonferroni post-hoc tests, 
using PASW 18.0 (IBM). Pearson correlation and UPGMA (Unweighted Pair Group Method 
using Arithmetic Mean) clustering were used to calculate dendrograms, using BioNumerics v5.10 
(Applied Maths). 
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Figure legends 
Figure 1 Systemic autoimmune responses in mice lacking secondary lymphoid organs 
(a) 3-month-old wild-type (C57BL/6), Ltbr−/−, Lta−/− , LIGHT−/− and Ltbr−/−Hox11−/− mice; 
percentage of mice with at least one anti-ENA reactivity. (b) 6-months-old Ltbr−/− mice (n=15); 
percentage of mice with reactivity against a specific ENA. (c) LIA of 6-month-old Ltbr−/− mice; 
wild-type mice and 3-month-old Rorγt-Ltb−/−- mice. (d) LTβR-Fc or control immunoglobulin (Ig) 
treated wild-type mice; percentage of mice with at least one anti-ENA reactivity. E denotes 
gestational day. *Anti-ENA were determined with LIA at the age of 3 months. **Anti-ENA were 
determined with LIA 12 weeks after the start of treatment. (e) 3-month-old cell-specific LT 
knock-out mice; percentage of mice with at least one anti-ENA reactivity. (f) Bone marrow cells 
from wild-type or Ltbr−/− mice were transferred at neonatal age into lethally-irradiated wild-type 
or Ltbr−/− mice; percentage of mice with at least one anti-ENA reactivity. Anti-ENA were 
determined with LIA at the age of 3 months. 
 
Figure 2 Development of antinuclear antibodies in lymphotoxin deficient mice is influenced by 
gut microbiota 
(a) Ltbr–/– mice were treated or not with antibiotics from birth (upper panel), conventionalized or 
germ free wild-type mice were treated with the LTβR-Fc fusion protein from gestational day 18 
until six weeks after birth (lower panel); percentage of mice with at least one anti-ENA reactivity. 
Anti-ENA were tested with LIA at the age of three months. (b) Cluster analysis of denaturing 
gradient gel electrophoresis of luminal samples of wild-type, anti-ENA positive and anti-ENA 
negative Ltbr-–/– mice. (c) Real-time PCR for SFB in luminal, mucosal and faecal samples of 
multiple anti-ENA positive and anti-ENA negative Ltbr–/– mice. Analysis with ANOVA, p=0.02 
for differences between groups, n = 4 mice per group. Data represent means±s.e.m. (d) LTβR-Fc 
treated wild-type or IL17R–/– mice; percentage of mice with at least one anti-ENA reactivity. E 
denotes gestational day. Anti-ENA were determined with LIA at the age of 3 months. 
 
Figure 3 Reduced IgA levels in mice and humans positive for antinuclear antibodies 
(a) Serum IgA levels of multiple anti-ENA positive and anti-ENA negative Ltbr–/– mice, and 
RAG2–/– mice (negative control). Analysis with student’s t-test, n = 6-22 mice per group. Data 
represent means±s.e.m. (b-c) Serum IgA and IgG levels of patients with systemic lupus 
erythematosus (SLE), rheumatoid arthritis (RA) and spondyloarthritis (SpA). Analysis with 
ANOVA with Bonferroni post-hoc tests: ***P < 0.001, NS, not significant (P > 0.05), n = 53-65 
patients per group. Data represent means±s.e.m. 
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Supplementary figure legends 
Supplementary figure 1 Validation of sensitivity of line immunoassay for mouse anti-
extractable nuclear antigen 
(a) 16-week-old MRL/lpr−/− mice (n = 20); percentage of mice with reactivity against a specific 
ENA. (b) 24-week-old (NZW/NZB)F1 mice (n = 16); percentage of mice with reactivity against a 
specific ENA. (c) Pristane-induced lupus in C57BL/6 mice (n = 10); analysis after 24 weeks, 
percentage of mice with reactivity against a specific ENA. (d) 24-week-old NOD mice (n = 21); 
percentage of mice with reactivity against a specific ENA. 
 
Supplementary figure 2 Absence of anti-dsDNA in Ltbr–/– mice 
Anti-dsDNA IgG levels in 3-month-old wild-type (C57BL/6) and Ltbr–/– mice. 7‐8 months 
(NZW/NZB) F1 were used as positive control. No significant difference was found between 
wild-type and Ltbr–/– mice, n = 5–8 mice per group. Data represent means±s.e.m.  
 
Supplementary figure 3 Absence of specific autoimmune pathologic features in Ltbr–/– mice 
(a) Representative images of interscapular skin (Masson trichrome, 20x magnification), 
esophagus (Masson trichrome, 100x magnification) and kidney (Periodic acid‐Schiff, 400x 
magnification) of 12-month-old wild-type and Ltbr–/– mice are shown. (b) Histological scores of 
different organs of 12-month-old wild-type and Ltbr–/– mice. No significant differences were 
found, n = 7 – 11 per group. Data represent means±s.e.m.  
 
Supplementary figure 4 LTβR expression in the thymic stroma is not required for anti-ENA 
development 
(a) Thymic reconstitution was analyzed by counting total cell number and flow cytometry for cell 
percentages. Numbers represent the percentages within the indicated regions (left panel). No 
significant differences were found. Data represent means±s.e.m. (b) T cell reconstitution of 
spleen was assessed by flow cytometry. Numbers represent the percentages within the indicated 
regions. (c) Total IgG from nude mice engrafted with Ltbr–/– or wild‐type thymi was determined 
by ELISA. No significant differences were found. Data represent means±s.e.m. (d) Sera were 
collected 12 weeks after transplantation and tested for anti-ENA; percentage of mice with at least 
one anti-ENA reactivity. 
 Supplementary figure 5 Histological analysis of the gut of anti-ENA positive and negative Ltbr–
/– mice  
(a) Inflammatory scores of different part of the gut of 3-months-old Ltbr–/– mice are shown. No 
significant differences were found, n = 4 per group. Data represent means±s.e.m. (b) Scoring 
scheme. 
 
Supplementary figure 6 Histological analysis of the gut of anti-ENA positive and negative Ltbr–
/– mice Representative images of different regions of the gut are shown (haematoxylin and eosin 
staining left, Periodic acid‐Schiff staining right, electron microscopy bottom). 
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Scoring parameter Wild-type Ltbr/
Kidney - Glomerular score 2.2f0.25 1.6f0.29
Kidney - Interstitial inflammation 1.1f0.23 0.91f0.28
Kidney - Glomeral crescents 0.1f0.1 0.18f0.18
Kidney - Vascular inflammation 0.2f0.2 0.09f0.09
Skin sclerosis 286f42 228f40
Esophagal sclerosis 39f2.0 29f4.6
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Histologic scoring scheme
Score
Criterion 0 1 2 3 4
Goblet cells / - -- --- ---
Mucosa thickening / + ++ +++ +++
Inflammatory cells / + ++ +++ +++
Submucosa cell infiltration / / + ++ +++
Destruction of architecture / / / + ++
Ulcers (epithelial cell surface) 0% 0-25% 25-50% 50-75% 75-100%
Crypt abscesses 0 1-3 4-6 7-9 >10
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